Analyst Consensus ?
ConsensusHold50 ratings
Bullish2958.0%
Neutral1836.0%
Bearish36.0%
The Charles Schwab Corporation · SCHW · FY2026 Q1 · Calendar Q2 2026
Schwab record Q1: $6.5B revenue, $1.43 EPS beat, but shares slipped ~8%
Schwab's record Q1 pairs an EPS beat with continued strong client acquisition (~1.3M accounts, $158B net new assets), positioning it to compound earnings through wealth-advisory flows, AI-driven efficiency, higher cash rates, and a phased spot-crypto launch. The offsetting risk is rate and tape sensitivity: shares fell about 8% on the print despite the beat, and drifted another ~3% lower, signaling concern over net interest margin and revenue per trade. The setup is constructive but environment-dependent.
Reported Before market openNYSEFinancial Services
$173.03B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.43
Consensus $1.40
EPS surprise
+2.1%
Reported versus consensus
Reported revenue
$6.48B
Consensus $6.50B
Revenue surprise
-0.3%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-7.6%
Event window
SPY move
+0.2%
Same window
Abnormal move
-7.9%
Stock minus SPY
Volume
3.0×
Versus trailing sessions
Subsequent drift
-3.4%
Up to 20 sessions
SCHWSPY benchmark
Ask FN2 about SCHW FY2026 Q1
Transcript, numbers and history already loaded
Why did SCHW fall 7.6% after beating EPS estimates in FY2026 Q1?What changed in SCHW's guidance and outlook in FY2026 Q1?Give me the bull and bear case for SCHW after FY2026 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior quarter (Q3 2025, +27% revenue and +70% EPS growth), Q1 2026 growth normalized to +16% revenue and +38% adjusted EPS — still record levels but at a slower pace. The quarter added several concrete catalysts: the Forge acquisition closed (pre-IPO private shares), spot crypto was quantified at 75bps with a phased rollout, and the first client AI assistant was dated for June 2026. Notably, the stock fell ~7.9% on the day despite the EPS beat — its largest abnormal down-move of the window — with ~3.4% further drift and roughly 3x baseline volume, so the negative market reaction outweighed the headline beat.
Guidance delta
Maintained. Management kept its full-year outlook and expressed confidence that AI, digital assets, and private-market initiatives will sustain earnings growth through the cycle. The supplied analysis includes no specific numeric guidance range.
Key takeaways
- Record Q1 2026: revenue of $6.5B (+16% YoY) and adjusted EPS of $1.43 (+38%), an EPS beat versus the $1.40 estimate while revenue came in marginally short.
- Strong client growth: roughly 1.3M new brokerage accounts and $158B of core net new assets, lifting total client assets to about $11.8T.
- Forge acquisition closed, adding direct access to pre-IPO private shares.
- Spot crypto (Bitcoin, Ether) launching at 75bps with a phased client rollout beginning with an employee pilot.
- AI acceleration: the first client AI assistant launches in June 2026, with AI portfolio insights and AI-enabled experiences planned through 2026.
Management priorities
- Launch AI-driven portfolio insights and AI-enabled experiences across 2026.
- Introduce the first client AI assistant in June 2026 and expand its capabilities over time.
- Roll out the Schwab Crypto spot platform to clients in phases, adding more coins over time.
- Deploy private issuer equity services and expand Forge product offerings.
- Open roughly a dozen new branches in 2026 and roll out the Schwab Team Investor account for teens.
Follow SCHW with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$100.61Current
$56Low
$105.82Average
$145High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 27, 2026 |
| Argus Research | Buy | Buy | Maintain | Jul 23, 2026 |
| UBS | Buy | Buy | Maintain | Jul 22, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 22, 2026 |
| BMO Capital | Market Perform | Outperform | Downgrade | Jul 20, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 15, 2026 |
| TD Cowen | Buy | Buy | Maintain | May 15, 2026 |
| Raymond James | Outperform | Outperform | Maintain | May 15, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Apr 17, 2026 |
| Jefferies | Buy | Buy | Maintain | Apr 6, 2026 |
| Truist Securities | Buy | Buy | Maintain | Apr 1, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jan 12, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Dec 10, 2025 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 17, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 17, 2025 |
| Citizens Capital Markets | Market Perform | Market Perform | Maintain | Jul 21, 2025 |
| Citigroup | Buy | Buy | Maintain | Jul 21, 2025 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 11, 2025 |
| Redburn Atlantic | Neutral | Sell | Upgrade | Jun 9, 2025 |
| TD Securities | Buy | Buy | Maintain | May 20, 2025 |
| Goldman Sachs | Buy | Neutral | Upgrade | Apr 25, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Jun 26, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | May 5, 2023 |
| Redburn Partners | Sell | Neutral | Downgrade | Apr 20, 2023 |
| Erste Group | Buy | Hold | Upgrade | Oct 5, 2022 |
| Compass Point | Buy | Neutral | Upgrade | Apr 12, 2022 |
| Atlantic Equities | Overweight | Overweight | Maintain | Oct 5, 2021 |
| CFRA | Buy | Buy | Maintain | Apr 15, 2020 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 12, 2019 |
| Bank of America | Neutral | Buy | Downgrade | Jul 12, 2019 |
| Bernstein | Perform | Market Perform | Maintain | Apr 10, 2018 |
| Nomura Instinet | Neutral | Buy | Downgrade | Jul 24, 2017 |
| Instinet | Neutral | Buy | Downgrade | Jul 24, 2017 |
| Rosenblatt | Neutral | Neutral | Maintain | Jul 13, 2017 |
| SunTrust Robinson Humphrey | Buy | Hold | Upgrade | Dec 19, 2016 |
| CLSA | Outperform | Outperform | Maintain | Sep 22, 2016 |
| Nomura | Buy | Buy | Maintain | Jul 11, 2016 |
| Argus | Buy | Buy | Maintain | Mar 23, 2016 |
| PiperJaffray | Neutral | Overweight | Downgrade | Dec 18, 2015 |
| RBC Capital | Outperform | Outperform | Maintain | Mar 27, 2015 |
| Evercore Partners | Equal Weight | Underweight | Upgrade | Dec 16, 2013 |
| Evercore ISI Group | Equal Weight | Underweight | Upgrade | Dec 16, 2013 |
| ISI Group | Buy | Buy | Maintain | May 15, 2013 |
| Sterne Agee | Neutral | Neutral | Maintain | Mar 14, 2013 |
| BGB Securities | Sell | Sell | Maintain | Jul 13, 2012 |
| Topeka Capital | Hold | Hold | Maintain | Jul 11, 2012 |
| Topeka | Hold | Hold | Maintain | Jul 11, 2012 |
| Stifel Nicolaus | Hold | Hold | Maintain | Apr 24, 2012 |
| Stifel | Hold | Buy | Downgrade | Apr 24, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $100.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $135 | $105.24 | +34.2% | Aug 3, 2026 |
| Compass Point | Ed Engel | $135 | $105.24 | +34.2% | Aug 3, 2026 |
| Morgan Stanley | Michael Cyprys | $136 | $103.9 | +35.2% | Jul 27, 2026 |
| Argus Research | Stephen Biggar | $114 | $102.18 | +13.3% | Jul 23, 2026 |
| Raymond James | Patrick O'Shaughnessy | $145 | $99.79 | +44.1% | Jul 22, 2026 |
| UBS | Michael Brown | $128 | $99.96 | +27.2% | Jul 22, 2026 |
| Wolfe Research | Steven Chubak | $127 | $99.96 | +26.2% | Jul 21, 2026 |
| Piper Sandler | Analyst unavailable | $118 | $100.58 | +17.3% | Jul 21, 2026 |
| BMO Capital | Analyst unavailable | $105 | $101.56 | +4.4% | Jul 20, 2026 |
| Piper Sandler | Analyst unavailable | $112 | $101.1 | +11.3% | Jul 15, 2026 |
| Morgan Stanley | Analyst unavailable | $133 | $102.47 | +32.2% | Jul 10, 2026 |
| Barclays | Benjamin Budish | $122 | $102.19 | +21.3% | Jul 9, 2026 |
| UBS | Analyst unavailable | $122 | $102.79 | +21.3% | Jul 8, 2026 |
| Raymond James | Patrick O'Shaughnessy | $137 | $92.21 | +36.2% | May 15, 2026 |
| Deutsche Bank | Analyst unavailable | $128 | $92.61 | +27.2% | May 15, 2026 |
| Barclays | Analyst unavailable | $127 | $89.44 | +26.2% | May 15, 2026 |
| Argus Research | Analyst unavailable | $108 | $93.15 | +7.3% | Apr 20, 2026 |
| Morgan Stanley | Michael Cyprys | $125 | $91.22 | +24.2% | Apr 17, 2026 |
| Deutsche Bank | Analyst unavailable | $127 | $92.62 | +26.2% | Apr 17, 2026 |
| Morgan Stanley | Analyst unavailable | $135 | $94.27 | +34.2% | Apr 10, 2026 |
| Barclays | Benjamin Budish | $126 | $102.18 | +25.2% | Jan 26, 2026 |
| Deutsche Bank | Analyst unavailable | $131 | $104.87 | +30.2% | Jan 22, 2026 |
| Truist Financial | Analyst unavailable | $122 | $104.27 | +21.3% | Jan 22, 2026 |
| UBS | Analyst unavailable | $125 | $101.79 | +24.2% | Jan 22, 2026 |
| Barclays | Benjamin Budish | $125 | $101.79 | +24.2% | Jan 22, 2026 |
| Piper Sandler | Analyst unavailable | $105 | $101.18 | +4.4% | Jan 14, 2026 |
| Wolfe Research | Analyst unavailable | $120 | $100.17 | +19.3% | Jan 12, 2026 |
| Barclays | Analyst unavailable | $120 | $101.93 | +19.3% | Jan 8, 2026 |
| Wolfe Research | Analyst unavailable | $122 | $102.92 | +21.3% | Jan 7, 2026 |
| UBS | Analyst unavailable | $123 | $102.88 | +22.3% | Jan 7, 2026 |
| Truist Financial | Analyst unavailable | $120 | $103.57 | +19.3% | Jan 7, 2026 |
| Raymond James | Patrick O'Shaughnessy | $114 | $104.02 | +13.3% | Jan 5, 2026 |
| Morgan Stanley | Analyst unavailable | $148 | $98.82 | +47.1% | Dec 22, 2025 |
| Barclays | Analyst unavailable | $111 | $97.02 | +10.3% | Dec 12, 2025 |
| UBS | Michael Brown | $119 | $95.81 | +18.3% | Dec 11, 2025 |
| Morgan Stanley | Analyst unavailable | $139 | $93.73 | +38.2% | Nov 3, 2025 |
| Truist Financial | Analyst unavailable | $113 | $93.41 | +12.3% | Oct 17, 2025 |
| Goldman Sachs | Analyst unavailable | $114 | $93.41 | +13.3% | Oct 17, 2025 |
| Deutsche Bank | Brian Bedell | $120 | $93.41 | +19.3% | Oct 17, 2025 |
| Barclays | Analyst unavailable | $114 | $94.01 | +13.3% | Oct 8, 2025 |
| Truist Financial | Analyst unavailable | $112 | $92.49 | +11.3% | Oct 2, 2025 |
| Morgan Stanley | Michael Cyprys | $130 | $92.81 | +29.2% | Oct 1, 2025 |
| Deutsche Bank | Analyst unavailable | $113 | $91.03 | +12.3% | Sep 16, 2025 |
| Raymond James | Patrick O\'Shaughnessy | $99 | $95.25 | -1.6% | Jul 18, 2025 |
| Wells Fargo | Michael Brown | $102 | $93.1 | +1.4% | Jul 18, 2025 |
| Piper Sandler | Patrick Moley | $70 | $72.26 | -30.4% | Jan 7, 2025 |
| Barclays | Benjamin Budish | $95 | $81.47 | -5.6% | Dec 9, 2024 |
| Jefferies | Daniel Fannon | $84 | $71.96 | -16.5% | Oct 16, 2024 |
| Goldman Sachs | Alexander Blostein | $74 | $71.96 | -26.4% | Oct 16, 2024 |
| Morgan Stanley | Michael Cyprys | $68 | $71.96 | -32.4% | Oct 15, 2024 |
| JMP Securities | Devin Ryan | $84 | $71.96 | -16.5% | Oct 15, 2024 |
| JMP Securities | Devin Ryan | $82 | $64.75 | -18.5% | Jul 23, 2024 |
| Jefferies | Daniel Fannon | $88 | $73.39 | -12.5% | Jul 8, 2024 |
| Deutsche Bank | Brian Bedell | $81 | $72.54 | -19.5% | Jun 18, 2024 |
| Barclays | Benjamin Budish | $72 | $72.27 | -28.4% | May 27, 2024 |
| Barclays | Benjamin Budish | $75 | $72.34 | -25.5% | May 23, 2024 |
| Deutsche Bank | Brian Bedell | $83 | $72.65 | -17.5% | May 23, 2024 |
| Goldman Sachs | Alexander Blostein | $75 | $75.27 | -25.5% | May 23, 2024 |
| UBS | Brennan Hawken | $91 | $75.27 | -9.6% | May 23, 2024 |
| Piper Sandler | Patrick Moley | $85 | $71.23 | -15.5% | Apr 16, 2024 |
| Goldman Sachs | Alexander Blostein | $76 | $71.23 | -24.5% | Apr 16, 2024 |
| Wolfe Research | Steven Chubak | $84 | $72.33 | -16.5% | Apr 15, 2024 |
| Goldman Sachs | Alexander Blostein | $72 | $72.48 | -28.4% | Apr 15, 2024 |
| Morgan Stanley | Michael Cyprys | $71 | $72.37 | -29.4% | Apr 9, 2024 |
| Barclays | Benjamin Budish | $74 | $71.89 | -26.4% | Apr 8, 2024 |
| Deutsche Bank | Brian Bedell | $77 | $68.35 | -23.5% | Mar 19, 2024 |
| Wolfe Research | Steven Chubak | $74 | $67.4 | -26.4% | Mar 18, 2024 |
| JMP Securities | Devin Ryan | $73 | $57.38 | -27.4% | Jul 10, 2023 |
| Credit Suisse | Bill Katz | $66.5 | $54.06 | -33.9% | Apr 18, 2023 |
| Barclays | Charles Schwab | $56 | $50.77 | -44.3% | Apr 14, 2023 |
| Credit Suisse | Bill Katz | $67.5 | $56.68 | -32.9% | Mar 15, 2023 |
| UBS | Analyst unavailable | $97 | $85.98 | -3.6% | Jan 9, 2023 |
| Barclays | Analyst unavailable | $83 | $78.19 | -17.5% | Dec 19, 2022 |
| Deutsche Bank | Analyst unavailable | $101 | $78.58 | +0.4% | Nov 15, 2022 |
| Deutsche Bank | Brian Bedell | $80 | $63.39 | -20.5% | Jul 5, 2022 |
| Deutsche Bank | Brian Bedell | $84 | $63.28 | -16.5% | May 23, 2022 |
| Deutsche Bank | Brian Bedell | $98 | $68.54 | -2.6% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $123 | $69.95 | +22.3% | Apr 25, 2022 |
| Deutsche Bank | Brian Bedell | $111 | $70.32 | +10.3% | Apr 25, 2022 |
| UBS | Brennan Hawken | $72 | $70.32 | -28.4% | Apr 24, 2022 |
| Citigroup | Analyst unavailable | $90 | $71.13 | -10.5% | Apr 22, 2022 |
| Piper Sandler | Analyst unavailable | $100 | $73.27 | -0.6% | Apr 22, 2022 |
| Morgan Stanley | Michael Cyprys | $132 | $77.59 | +31.2% | Apr 21, 2022 |
| Compass Point | Chris Allen | $98 | $82.75 | -2.6% | Apr 16, 2022 |
| Deutsche Bank | Brian Bedell | $114 | $81.58 | +13.3% | Apr 11, 2022 |
| Goldman Sachs | Will Nance | $100 | $81.69 | -0.6% | Apr 8, 2022 |
| Piper Sandler | Richard Repetto | $110 | $81.69 | +9.3% | Apr 8, 2022 |
| Bank of America Securities | Craig Siegenthaler | $112 | $81.86 | +11.3% | Apr 5, 2022 |
| Deutsche Bank | Brian Bedell | $122 | $95.53 | +21.3% | Jan 17, 2022 |
| UBS | Brennan Hawken | $90 | $89.77 | -10.5% | Jan 4, 2022 |
| Wolfe Research | Steven Chubak | $90 | $83.19 | -10.5% | Oct 22, 2021 |
| Atlantic Equities | John Heagerty | $95 | $75.57 | -5.6% | Oct 5, 2021 |
| Compass Point | Christopher Allen | $75 | $74.1 | -25.5% | Oct 1, 2021 |
| Wells Fargo | Christopher Harris | $88 | $74.42 | -12.5% | Jun 2, 2021 |
| Barclays | Jeremy Campbell | $70 | $66.51 | -30.4% | Apr 23, 2021 |
Track every rating change on SCHW the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe Charles Schwab Corporation (SCHW) stands as a prominent financial services enterprise, delivering a comprehensive suite of offerings that encompass wealth management, securities trading and brokerage, banking services, asset administration, custodial solutions, and financial planning advice. Its operations are primarily structured around two core divisions: Investor Services and Advisor Services. The Investor Services segment caters directly to individual retail clients, furnishing a range of services such as brokerage accounts, investment guidance, banking and trust administration, retirement planning, and corporate brokerage offerings. It further assists businesses with the full-service recordkeeping of equity compensation plans (e.g., stock options, restricted stock, performance shares), provides clearing services for retail investors and mutual funds, and offers compliance solutions. Conversely, the Advisor Services segment provides a robust support system for independent investment advisors.…
Historical context
All SCHW earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| PUK Prudential plc | FY2026 Q2 · Calendar Q3 2026 | -40.9% | -0.5% | Prudential sustains growth and capital returns focus in H1 2026 |
| CM Canadian Imperial Bank of Commerce | FY2026 Q3 · Calendar Q3 2026 | +8.9% | -2.8% | CIBC Q3: Broad growth, resilient credit and expanded AI rollout |
| TD The Toronto-Dominion Bank | FY2026 Q3 · Calendar Q3 2026 | +13.8% | +1.4% | TD emphasizes growth investments alongside disciplined capital management |
| RY Royal Bank of Canada | FY2026 Q3 · Calendar Q3 2026 | +6.2% | -1.3% | RBC reports record Q3 earnings while investing for growth |
| AFRM Affirm Holdings, Inc. | FY2026 Q4 · Calendar Q3 2026 | +1230.3% | +0.3% | Affirm's most profitable quarter shifts focus to product execution |
Latest beats and misses
Who reports nextBeat on EPS
- SNXFY2026 Q3 · September 24, 2026+20.9% EPS-9.9% move
- DRIFY2027 Q1 · September 24, 20260.0% EPS-3.0% move
- CTASFY2027 Q1 · September 23, 2026+3.0% EPS-3.4% move
- PAYXFY2027 Q1 · September 23, 2026+1.5% EPS-8.8% move
- GISFY2027 Q1 · September 23, 2026+4.6% EPS+1.0% move
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
Get the SCHW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-09-25T11:21:02.885660+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-25T11:21:02.882735+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-25. For educational purposes only; not investment advice.